Question Everything. See who's reporting it.

Symbiotec Pharmalab IPO Gets 80% Subscription On First Day

Source: Free Press Journal

The story in brief

Symbiotec Pharmalab Ltd's IPO received 80% subscription on the first day of bidding, with retail investors subscribing 95% and QIBs 35%. The offering, valued at up to Rs 6,350 crore, includes a fresh issue of Rs 150 crore and an OFS of Rs 1,607 crore. Shares are set to list on BSE and NSE on September 1. The company, a global leader in corticosteroid APIs, plans to use proceeds for debt repayment and corporate purposes.

NEWXFree on Android and iPhone. Open in NEWX